Literature DB >> 1659196

Vulvitis and vulvovaginitis: cutaneous considerations.

M McKay1.   

Abstract

Vulvar dermatoses (previously dystrophies) include psoriasis, allergic or irritant reactions, lichen sclerosus, lichen simplex chronicus, lichen planus, and tinea. Some of these have bullous or erosive forms, but they differ from the immune-mediated vesiculobullous disease group, which includes vulvar pemphigus, benign familial pemphigus, pemphigoid, linear IgA disease, and dermatitis herpetiformis. Vulvar ulcers can occur in dermatoses resulting from systemic disease (Behçet's syndrome, lupus, pellagra, and Reiter's disease) or malignancies resembling dermatoses (extramammary Paget's disease, squamous cell carcinoma, and vulvar intraepithelial neoplasia). Many vulvar dermatoses itch or burn. Vulvodynia occurs with irritant and allergic dermatitis, vulvar dermatoses, complications of steroid use, candidiasis, papillomatosis, vestibulitis, or essential (dysesthetic) vulvodynia. Diagnostic tests (potassium hydroxide, cultures, and biopsy) should establish the diagnosis and therapy should be specific. Few skin diseases are curable but all are treatable; effective management is defined by whether a medication reliably controls outbreaks or symptoms when it is used. Patience is recommended, because treatment may take weeks or months.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659196     DOI: 10.1016/s0002-9378(12)90723-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Nontrichomonal Purulent Vaginitis: Clinical Approach.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.663

Review 2.  Female Sexual Dysfunctions and Urogynecological Complaints: A Narrative Review.

Authors:  Lavinia Mosca; Gaetano Riemma; Andrea Braga; Matteo Frigerio; Alessandro Ferdinando Ruffolo; Mattia Dominoni; Gaetano Maria Munno; Stefano Uccella; Maurizio Serati; Antonio Raffone; Stefano Salvatore; Marco Torella
Journal:  Medicina (Kaunas)       Date:  2022-07-23       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.